Frequent expression of p53 protein without mutation in the atypical epithelium of human bronchus

Kentaro Wakamatsu, Yoichi Nakanishi, Koichi Takayama, Hiroyuki Miyazaki, Kenshi Hayashi, Nobuyuki Hara

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

We investigated the correlation between p53 protein levels and mutations in the p53 gene of atypical bronchial epithelium (ABE). Protein levels were analyzed by immunohistochemistry, whereas mutations were assessed by polymerase chain reaction-single-strand conformational polymorphism (PCR-SSCP) and direct sequencing. A total of 78 formalin-fixed, paraffin-embedded bronchial biopsy specimens that had been diagnosed to be ABE were retrieved from the archives and examined. p53 protein was expressed in 44 of the 78 (56%) specimens overall. However, when pathologically classified, 38% of hyperplasias, 58% of metaplasias, and 73% of dysplasias were positive, indicating that an increased frequency of p53 expression correlated with the severity of ABE (P = 0.042). Among the 44 specimens that expressed p53 protein, 40 (91%) did not reveal mutations by PCR-SSCP. In the four specimens with abnormal PCR-SSCP bands, p53 gene mutation was identified by direct sequencing and revealed the same point mutation at codon 248 (CGG-to-CTG transversion) of exon 7 in all four specimens. These four specimens were dysplasias derived from patients with lung cancer. p53 protein expression in ABE was associated with the wild-type gene in most cases; therefore, wild-type p53 protein expressed in ABE might have a protective function from lung carcinogenesis, and mutation of p53 gene may be a late event in the sequential steps of lung carcinogcnesis.

Original languageEnglish
Pages (from-to)209-215
Number of pages7
JournalAmerican journal of respiratory cell and molecular biology
Volume21
Issue number2
DOIs
Publication statusPublished - Jan 1 1999

Fingerprint

Bronchi
Epithelium
Mutation
Polymerase chain reaction
p53 Genes
Genes
Polymorphism
Proteins
Polymerase Chain Reaction
Lung
Biopsy
Metaplasia
Point Mutation
Codon
Paraffin
Formaldehyde
Hyperplasia
Exons
Lung Neoplasms
Carcinogenesis

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Pulmonary and Respiratory Medicine
  • Clinical Biochemistry
  • Cell Biology

Cite this

Frequent expression of p53 protein without mutation in the atypical epithelium of human bronchus. / Wakamatsu, Kentaro; Nakanishi, Yoichi; Takayama, Koichi; Miyazaki, Hiroyuki; Hayashi, Kenshi; Hara, Nobuyuki.

In: American journal of respiratory cell and molecular biology, Vol. 21, No. 2, 01.01.1999, p. 209-215.

Research output: Contribution to journalArticle

Wakamatsu, Kentaro ; Nakanishi, Yoichi ; Takayama, Koichi ; Miyazaki, Hiroyuki ; Hayashi, Kenshi ; Hara, Nobuyuki. / Frequent expression of p53 protein without mutation in the atypical epithelium of human bronchus. In: American journal of respiratory cell and molecular biology. 1999 ; Vol. 21, No. 2. pp. 209-215.
@article{e28f71483f8c4f9484b016e1af1b3e0e,
title = "Frequent expression of p53 protein without mutation in the atypical epithelium of human bronchus",
abstract = "We investigated the correlation between p53 protein levels and mutations in the p53 gene of atypical bronchial epithelium (ABE). Protein levels were analyzed by immunohistochemistry, whereas mutations were assessed by polymerase chain reaction-single-strand conformational polymorphism (PCR-SSCP) and direct sequencing. A total of 78 formalin-fixed, paraffin-embedded bronchial biopsy specimens that had been diagnosed to be ABE were retrieved from the archives and examined. p53 protein was expressed in 44 of the 78 (56{\%}) specimens overall. However, when pathologically classified, 38{\%} of hyperplasias, 58{\%} of metaplasias, and 73{\%} of dysplasias were positive, indicating that an increased frequency of p53 expression correlated with the severity of ABE (P = 0.042). Among the 44 specimens that expressed p53 protein, 40 (91{\%}) did not reveal mutations by PCR-SSCP. In the four specimens with abnormal PCR-SSCP bands, p53 gene mutation was identified by direct sequencing and revealed the same point mutation at codon 248 (CGG-to-CTG transversion) of exon 7 in all four specimens. These four specimens were dysplasias derived from patients with lung cancer. p53 protein expression in ABE was associated with the wild-type gene in most cases; therefore, wild-type p53 protein expressed in ABE might have a protective function from lung carcinogenesis, and mutation of p53 gene may be a late event in the sequential steps of lung carcinogcnesis.",
author = "Kentaro Wakamatsu and Yoichi Nakanishi and Koichi Takayama and Hiroyuki Miyazaki and Kenshi Hayashi and Nobuyuki Hara",
year = "1999",
month = "1",
day = "1",
doi = "10.1165/ajrcmb.21.2.3524",
language = "English",
volume = "21",
pages = "209--215",
journal = "American Journal of Respiratory Cell and Molecular Biology",
issn = "1044-1549",
publisher = "American Thoracic Society",
number = "2",

}

TY - JOUR

T1 - Frequent expression of p53 protein without mutation in the atypical epithelium of human bronchus

AU - Wakamatsu, Kentaro

AU - Nakanishi, Yoichi

AU - Takayama, Koichi

AU - Miyazaki, Hiroyuki

AU - Hayashi, Kenshi

AU - Hara, Nobuyuki

PY - 1999/1/1

Y1 - 1999/1/1

N2 - We investigated the correlation between p53 protein levels and mutations in the p53 gene of atypical bronchial epithelium (ABE). Protein levels were analyzed by immunohistochemistry, whereas mutations were assessed by polymerase chain reaction-single-strand conformational polymorphism (PCR-SSCP) and direct sequencing. A total of 78 formalin-fixed, paraffin-embedded bronchial biopsy specimens that had been diagnosed to be ABE were retrieved from the archives and examined. p53 protein was expressed in 44 of the 78 (56%) specimens overall. However, when pathologically classified, 38% of hyperplasias, 58% of metaplasias, and 73% of dysplasias were positive, indicating that an increased frequency of p53 expression correlated with the severity of ABE (P = 0.042). Among the 44 specimens that expressed p53 protein, 40 (91%) did not reveal mutations by PCR-SSCP. In the four specimens with abnormal PCR-SSCP bands, p53 gene mutation was identified by direct sequencing and revealed the same point mutation at codon 248 (CGG-to-CTG transversion) of exon 7 in all four specimens. These four specimens were dysplasias derived from patients with lung cancer. p53 protein expression in ABE was associated with the wild-type gene in most cases; therefore, wild-type p53 protein expressed in ABE might have a protective function from lung carcinogenesis, and mutation of p53 gene may be a late event in the sequential steps of lung carcinogcnesis.

AB - We investigated the correlation between p53 protein levels and mutations in the p53 gene of atypical bronchial epithelium (ABE). Protein levels were analyzed by immunohistochemistry, whereas mutations were assessed by polymerase chain reaction-single-strand conformational polymorphism (PCR-SSCP) and direct sequencing. A total of 78 formalin-fixed, paraffin-embedded bronchial biopsy specimens that had been diagnosed to be ABE were retrieved from the archives and examined. p53 protein was expressed in 44 of the 78 (56%) specimens overall. However, when pathologically classified, 38% of hyperplasias, 58% of metaplasias, and 73% of dysplasias were positive, indicating that an increased frequency of p53 expression correlated with the severity of ABE (P = 0.042). Among the 44 specimens that expressed p53 protein, 40 (91%) did not reveal mutations by PCR-SSCP. In the four specimens with abnormal PCR-SSCP bands, p53 gene mutation was identified by direct sequencing and revealed the same point mutation at codon 248 (CGG-to-CTG transversion) of exon 7 in all four specimens. These four specimens were dysplasias derived from patients with lung cancer. p53 protein expression in ABE was associated with the wild-type gene in most cases; therefore, wild-type p53 protein expressed in ABE might have a protective function from lung carcinogenesis, and mutation of p53 gene may be a late event in the sequential steps of lung carcinogcnesis.

UR - http://www.scopus.com/inward/record.url?scp=0033172699&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033172699&partnerID=8YFLogxK

U2 - 10.1165/ajrcmb.21.2.3524

DO - 10.1165/ajrcmb.21.2.3524

M3 - Article

C2 - 10423403

AN - SCOPUS:0033172699

VL - 21

SP - 209

EP - 215

JO - American Journal of Respiratory Cell and Molecular Biology

JF - American Journal of Respiratory Cell and Molecular Biology

SN - 1044-1549

IS - 2

ER -